Illumina Signs SNP Genotyping Agreement With the University of Cambridge.
Illumina Inc. announced that it has signed a commercial agreement with the University of Cambridge to provide single nucleotide polymorphism genotyping services on a sample collection provided by the University's Cambridge Institute for Medical Research which houses the Juvenile Diabetes Research Foundation and Wellcome Trust funded Diabetes and Inflammation Laboratory. Under the terms of the agreement, Illumina will design functional assays for the SNP loci provided by CIMR, and then use its BeadArray technology to genotype specified SNPs in the set of roughly 3000 samples.
